TMDX's sales rose 41%, and operating income increased from $23.3 million to $28.1 million. Higher organ volume helped, though logistics services and the PAD Aviation acquisition also contributed to sales growth.
More organ transplants through the National OCS Program, along with logistics services and PAD Aviation, helped drive the sales increase. Operating income rose too, showing that the gains reached beyond sales.
Follow TransMedics Group, Inc. (TMDX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TMDX